| Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963) |
|---|
| 06/16/2010 | CN1970558B lactic acid base puerarin derivative preparation method |
| 06/15/2010 | US7737177 Combining solution of pseudomonic acid in water-immiscible solvent with suspension or solution of calcium C2-C12 organic carboxylate in aqueous solvent to form aqueous and nonaqueous phases, wherein mupirocin calcium dihydrate precipitates |
| 06/10/2010 | WO2010064735A1 Quinolone compound and pharmaceutical composition |
| 06/10/2010 | WO2010002804A3 Method and compositions for inhibition of double stranded dna viruses |
| 06/10/2010 | US20100145071 Small molecule inhibitors of rotamase enzyme activity |
| 06/10/2010 | CA2745019A1 Quinolone compound and pharmaceutical composition |
| 06/09/2010 | CN1735607B 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (PI) 3-kinase inhibitors and their use in the treatment of cancer |
| 06/09/2010 | CN101730693A Process for producing macrolide compound and intermediate therefor |
| 06/09/2010 | CN101730692A Pyridazinone derivatives useful as glucan synthase inhibitors |
| 06/09/2010 | CN101730689A 6 -acyloxy- 7-meth0xy- 2, 2 -dimethylchromane compounds and their use as pigmentation-regulators |
| 06/09/2010 | CN101723940A Bithiophene compound and pharmaceutical composite and application thereof |
| 06/09/2010 | CN101723939A Isopentenyl-oxyl substituted dehydrogenized silybin ether and preparation method and application thereof |
| 06/09/2010 | CN101723938A Synthesis processes and bioactivities of 3-aromatic (hetero)-6,8-dyhydroxy isoflavonoid compounds |
| 06/03/2010 | WO2010062265A1 Therapeutic macrolide compounds and their use |
| 06/03/2010 | WO2010060955A1 Novel 2-morpholino-3-amido-pyridine derivatives and their medical use |
| 06/03/2010 | WO2010060379A1 Ether compounds with nitrogen-containing 5-member heterocycle and the uses thereof |
| 06/03/2010 | WO2009154300A3 Heterocyclic compound and use thereof |
| 06/03/2010 | US20100137371 Novel Pharmaceutical Compounds |
| 06/03/2010 | US20100137298 Biaryl Sulfonamides and Methods for Using Same |
| 06/02/2010 | EP1712642B1 Method of examining sensitivity of cancer cell to anticancer agent |
| 06/02/2010 | CN1809559B Pyrazole derivatives as phosphodiesterase 4 inhibitors |
| 06/01/2010 | US7728127 Cross-linked glycopeptide-cephalosporin antibiotics |
| 06/01/2010 | US7727511 Agents for imaging soluble a-beta |
| 06/01/2010 | CA2448737C Viral polymerase inhibitors |
| 05/27/2010 | WO2010059611A2 Inhibitors of diacylglycerol acyltransferase |
| 05/27/2010 | WO2010059393A1 Serotonin receptor modulators |
| 05/27/2010 | US20100130738 Pyrazolone derivative and pde inhibitor containing the same as active ingredient |
| 05/27/2010 | US20100129563 Sensitizer for cationic photoinitiators |
| 05/27/2010 | US20100127211 Five-ring liquid crystal compound having cf20 bonding group, liquid crystal composition, and liquid crystal display device |
| 05/27/2010 | CA2743497A1 Inhibitors of diacylglycerol acyltransferase |
| 05/26/2010 | EP2188281A1 Modulation of immune responses by administration of roxithromycin or its derivative |
| 05/26/2010 | EP2187742A1 Benzylbenzene derivatives and methods of use |
| 05/26/2010 | EP1651639B1 Benzofuran derivatives and their use in the treatment of microbial infections |
| 05/26/2010 | EP1315709B1 Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 05/26/2010 | CN1875022B Tocopherol-modified therapeutic drug compounds |
| 05/26/2010 | CN101712676A Water soluble puerarin derivatives and preparation method and application thereof |
| 05/25/2010 | US7723536 Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof |
| 05/25/2010 | US7723321 such as 4-[(5,7-difluoro-3,4-dihydro-2H-chromen-4-yl)oxyl]-N,N,2-trimethyl-1H-benzimidazole -6-carboxamide, used as acid pump antagonists for the treatment of gastrointestinal disorders |
| 05/25/2010 | CA2248303C Perfluorinated amide salts and their uses as ionic conducting materials |
| 05/20/2010 | WO2010057121A1 Pyrazine compounds as phosphodiesterase 10 inhibitors |
| 05/20/2010 | WO2010056585A2 Heteroaryl diamide compounds useful as mmp-13 inhibitors |
| 05/20/2010 | WO2010056320A2 Pi3k/mtor kinase inhibitors |
| 05/20/2010 | WO2010055267A1 Carbamate derivatives of alkyl-heterocycles, preparation thereof and therapeutic use thereof |
| 05/20/2010 | US20100125090 Modulators of ATP-Binding Cassette Transporters |
| 05/20/2010 | US20100124543 Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors |
| 05/20/2010 | CA2743558A1 Carbamate derivatives of alkyl-heterocycles, preparation thereof and therapeutic use thereof |
| 05/20/2010 | CA2743146A1 Heteroaryl diamide compounds useful as mmp-13 inhibitors |
| 05/20/2010 | CA2743015A1 Pi3k/mtor kinase inhibitors |
| 05/20/2010 | CA2742993A1 Pyrazine compounds as phosphodiesterase 10 inhibitors |
| 05/19/2010 | EP2185502A1 Pyridinecarboxamide and benzamide derivatives as taar1 ligands |
| 05/19/2010 | EP1330454B1 Benzopyranyl heterocycle derivatives, process for preparation thereof, and pharmaceutical compositions containing them |
| 05/19/2010 | CN101033226B 1-furylmethyl-3-substituted indolin-2-one derivative |
| 05/18/2010 | US7718695 Inclusion compounds of fumagillol derivative or its salt, and pharmaceutical compositions comprising the same |
| 05/18/2010 | CA2422371C Pyrazole compounds useful as protein kinase inhibitors |
| 05/18/2010 | CA2422367C Pyrazole compounds useful as protein kinase inhibitors |
| 05/14/2010 | WO2010053182A1 Kynurenine production inhibitor |
| 05/12/2010 | EP2183225A1 Cyclic amine substituted pyrimidinediamines as pkc inhibitors |
| 05/12/2010 | EP2099762B1 Antibacterial quinoline derivatives |
| 05/12/2010 | CN1671856B Novel physiologically active substances |
| 05/12/2010 | CN1580043B Anti malignant tumour southern radix bupleuri extract preparing method |
| 05/11/2010 | US7713931 Cross-linked glycopeptide-cephalosporin antibiotics |
| 05/11/2010 | CA2422299C Triazole compounds useful as protein kinase inhibitors |
| 05/11/2010 | CA2248244C Heterocyclic aromatic anion salts, and their uses as ionic conducting materials |
| 05/06/2010 | WO2010051277A1 Process for the production of alpha-tocotrienol and derivatives |
| 05/06/2010 | WO2010050445A1 Bicyclic compound |
| 05/06/2010 | US20100113792 Benzylpiperizine compound |
| 05/06/2010 | US20100113585 Compositions and methods for treating cancer |
| 05/06/2010 | US20100113489 Modulators of chemokine receptor activity, crystalline forms and process |
| 05/06/2010 | US20100113436 Dispiro tetraoxane compounds and their use in the treatment of malaria and/or cancer |
| 05/06/2010 | CA2741767A1 Process for the production of alpha-tocotrienol and derivatives |
| 05/05/2010 | EP2181985A1 Antiviral Agent |
| 05/05/2010 | EP1987001B1 1-phenethylpiperidine derivatives and their use as opioid receptor ligands |
| 05/05/2010 | CN101702907A Piperazine compounds with a herbicidal action |
| 05/05/2010 | CN101702905A Functionally selective alpha 2C adrenoreceptor agonists |
| 05/04/2010 | US7709664 E.g., 3-arylmethyl-7-hydroxy-coumarins as intermediates; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 05/04/2010 | US7709500 Chemical compounds |
| 04/29/2010 | US20100105767 Compounds, compositions and methods |
| 04/29/2010 | US20100105739 Modulators of atp-binding cassette transporters |
| 04/29/2010 | US20100102274 Chroman Compounds |
| 04/28/2010 | EP2178862A1 Chelators, paramagnetic chelates thereof and their use as contrast agents in magnetic resonance imaging (mri) |
| 04/28/2010 | EP2178860A1 Chelators, paramagnetic chelates thereof and their use as contrast agents in magnetic resonance imaging (mri) |
| 04/28/2010 | EP2178858A1 Novel heterocyclic compounds as mglu5 antagonists |
| 04/28/2010 | EP2178371A1 Heterocyclic modulators of cannabinoid receptors |
| 04/28/2010 | CN1747929B Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor |
| 04/27/2010 | US7705020 Benzimidazolone carboxylic acid derivatives |
| 04/27/2010 | US7704960 Administering Erythromycin A having had the cladinose moiety in the 3-position removed by acidolysis to produce an antiinflammatory agent having no antibiotic properties; chronic respiratory system disorders; cytokine suppressive antiinflammatory drugs; antiarthritic agents; antiischemic agents |
| 04/27/2010 | CA2493667C Vanilloid receptor ligands and their use in treatments |
| 04/27/2010 | CA2449180C Viral polymerase inhibitors |
| 04/27/2010 | CA2422378C Pyrazole compounds useful as protein kinase inhibitors |
| 04/22/2010 | US20100099661 Antibacterial aminoglycoside analogs |
| 04/21/2010 | CN1854134B Piperazine compounds, their preparation method and pharmaceutical composition containing same |
| 04/20/2010 | US7700772 Amino heterocyclic modulators of chemokine receptor activity |
| 04/20/2010 | CA2581865C Indazolone derivatives as 11b-hsd1 inhibitors |
| 04/20/2010 | CA2510540C Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 04/20/2010 | CA2494067C Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
| 04/15/2010 | WO2010042477A1 Benzodioxan analogues as alpha2c adrenergic receptor modulators |
| 04/15/2010 | WO2010041670A1 Diolefin compound, epoxy resin, curable resin composition and cured product |
| 04/15/2010 | WO2010040843A2 Dibenzocycloheptanone derivatives and pharmaceutical agents containing said compounds |
| 04/15/2010 | WO2010022033A3 Therapeutic substituted pyrroles |
| 04/15/2010 | US20100094026 Method of screening compound useful in treating allergic disease |